The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Anxiety and depression in multiple sclerosis patients around diagnosis
Abstract
Objectives To prospectively identify anxiety and depressive symptoms, and their predictors, during the multiple sclerosis (MS) peridiagnostic period.Methods The Hospital Anxiety and Depression Scale (HADS) was administered during diagnostic workup (baseline), and one and six months after diagnosis disclosure, to SIMS-Trial participants (ISRCTN81072971).Results Of 197 screened patients, 120 (61%) were diagnosed with MS. At baseline, median HADS anxiety (HADS-A) score was 7.0 (interquartile range [IQR] 5.0-9.5), ≥8 (anxiety cut-off) in 43% (95% confidence interval [CI] 34%-52%). Median HADS depression (HADS-D) was 3.0 (IQR 1.0-5.0), ≥8 (depression cut-off) in 11% (95% CI 5%-16%). Independent predictors of anxiety were female sex (odds ratio [OR] 2.8, 95% CI 1.1-7.2) and HADS-D score (OR 20.8, 95% CI 2.5-175.5). The only predictor of depressive symptoms was HADS-A score (OR 20.0, 95% CI 2.8-260.9). Anxiety symptoms had decreased slightly but significantly (p<0.001) at six months. Depressive symptoms remained low.Conclusions Anxiety was prominent in the period surrounding MS diagnosis disclosure, particularly in women. A slight but significant reduction occurred six months after diagnosis disclosure. Depressive symptoms were less common and stable over time. In addition to sex, depressive symptoms were the only variable independently associated with anxiety.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition to the physical consequences, receiving an MS diagnosis and experiencing MS symptoms and progression of the disease have been associated with depression and anxiety (Giordano et al., 2011).”
From Self-concept, illness acceptance and depressive and anxiety symptoms in people with multiple sclerosis. (2021) · cites this paper as Giordano et al., 2011
In the citing paper
“Depression and anxiety have been found to be common in individuals with MS and have been reported to be at clinically high levels especially in the early stages of the illness [2–4].”
In the citing paper
“Firstly, the time around receiving a MS diagnosis has been shown to be when individuals experience significantly higher levels of depression and anxiety [2, 4, 11, 16].”
Citations
Cites
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria
Polman, C. H., Reingold, S. C., Banwell, B., Clanet, M., Cohen, J. A., Filippi, M., Fujihara, K., Havrdova, E., Hutchinson, M., Kappos, L., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22366 · Cited by 9,802
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
Polman, C. H., Reingold, S. C., Edan, G., Filippi, M., Hartung, H., Kappos, L., Lublin, F. D., Metz, L. M., McFarland, H. F., O'Connor, P. W., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20703 · Cited by 5,017
The handbook of psychological testing
Kline, P. (1993) · Choice Reviews Online · doi:10.5860/choice.31-1802 · Cited by 3,541
Cytokines sing the blues: inflammation and the pathogenesis of depression
Raison, C. L., Capuron, L., & Miller, A. H. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.11.006 · Cited by 3,009
Herrmann, C. (1997) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(96)00216-4 · Cited by 2,885
The handbook of psychological testing, 2nd ed.
Kline, P. (1993) · Cited by 1,248
Depression in multiple sclerosis: a review
Siegert, R. J. (2005) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.054635 · Cited by 718
Chwastiak, L., Ehde, D. M., Gibbons, L. E., Sullivan, M., Bowen, J. D., & Kraft, G. H. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.11.1862 · Cited by 555
Costantini, M., Musso, M., Viterbori, P., Bonci, F., Mastro, L. D., Garrone, O., Venturini, M., & Morasso, G. (1999) · Supportive Care in Cancer · doi:10.1007/s005200050241 · Cited by 542
Cited by
Sorted by citations
The link between multiple sclerosis and depression
Feinstein, A., Magalhaes, S., Richard, J., Audet, B., & Moore, C. S. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.139 · Cited by 550
Prevalence and concurrence of anxiety, depression and fatigue over time in multiple sclerosis
Wood, B., van der Mei, I., Ponsonby, A.-L., Pittas, F., Quinn, S., Dwyer, T., Lucas, R., & Taylor, B. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458512450351 · Cited by 294
Jones, K. H., Ford, D. V., Jones, P. A., John, A., Middleton, R. M., Lockhart-Jones, H., Osborne, L. A., & Noble, J. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041910 · Cited by 190
A systematic review of anxiety amongst people with Multiple Sclerosis
Butler, E., Matcham, F., & Chalder, T. (2016) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2016.10.003 · Cited by 111
Psychological consequences of COVID-19 pandemic in Italian MS patients: Signs of resilience?
Capuano, R., Altieri, M., Bisecco, A., d’Ambrosio, A., Docimo, R., Buonanno, D., Matrone, F., Giuliano, F., Tedeschi, G., Santangelo, G., et al. (2021) · Journal of Neurology · doi:10.1007/s00415-020-10099-9 · Cited by 88
Hoang, H., Laursen, B., Stenager, E. N., & Stenager, E. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458515588973 · Cited by 88
Terrill, A. L., Hartoonian, N., Beier, M. L., Salem, R., & Alschuler, K. N. (2014) · International Journal of MS Care · doi:10.7224/1537-2073.2014-008 · Cited by 84
Karimi, S., Andayeshgar, B., & Khatony, A. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02579-z · Cited by 85
Kopke, S., Kern, S., Ziemssen, T., Berghoff, M., Kleiter, I., Marziniak, M., Paul, F., Vettorazzi, E., Pottgen, J., Fischer, K., et al. (2014) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-306441 · Cited by 77
The risk of Bipolar Disorders in Multiple Sclerosis.
Carta, M., Moro, M., Lorefice, L., Trincas, G., Cocco, E., del Giudice, E., Fenu, G., Colom, F., & Marrosu, M. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.11.008 · Cited by 66
Anxiety state affects information processing speed in patients with multiple sclerosis
Goretti, B., Viterbo, R. G., Portaccio, E., Niccolai, C., Hakiki, B., Piscolla, E., Iaffaldano, P., Trojano, M., & Amato, M. P. (2013) · Neurological Sciences · doi:10.1007/s10072-013-1544-0 · Cited by 66
Self-citationZeraati, M., Enayati, M., Kafami, L., Shahidi, S. H., & Salari, A. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107685 · Cited by 65
The prevalence of anxiety and associated factors in persons with multiple sclerosis
Pham, T., Jetté, N., Bulloch, A. G. M., Burton, J. M., Wiebe, S., & Patten, S. B. (2018) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2017.11.003 · Cited by 64
Nigro, S. L., Passamonti, L., Riccelli, R., Toschi, N., Rocca, F., Valentino, P., Nisticò, R., Fera, F. S., & Quattrone, A. (2014) · Multiple Sclerosis Journal · doi:10.1177/1352458514558474 · Cited by 61
Zolbanin, J. M., Doosti, M.-H., Kosari‐Nasab, M., & Salari, A. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.03.016 · Cited by 57
Anxiety, depression and fatigue at 5‐year review following CNS demyelination
Simpson, S., Tan, H., Otáhal, P., Taylor, B. V., Ponsonby, A., Lucas, R. M., Blizzard, L., Valery, P. C., Lechner‐Scott, J., Shaw, C., et al. (2016) · Acta Neurologica Scandinavica · doi:10.1111/ane.12554 · Cited by 61
Calandri, E., Graziano, F., Borghi, M., & Bonino, S. (2016) · Journal of Happiness Studies · doi:10.1007/s10902-016-9818-x · Cited by 59
Valentine, T. R., Alschuler, K. N., Ehde, D. M., & Kratz, A. L. (2022) · Multiple Sclerosis Journal · doi:10.1177/13524585211023352 · Cited by 55
Giovannetti, A. M., Quintas, R., Tramacere, I., Giordano, A., Confalonieri, P., Messmer Uccelli, M., Solari, A., & Pakenham, K. I. (2020) · PLOS ONE · doi:10.1371/journal.pone.0231380 · Cited by 53
Self-citationDecision-Making in Multiple Sclerosis Consultations in Italy: Third Observer and Patient Assessments
Pietrolongo, E., Giordano, A., Kleinefeld, M., Confalonieri, P. A., Lugaresi, A., Tortorella, C., Pugliatti, M., Radice, D., Goss, C., Heesen, C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060721 · Cited by 51
Self-citationPsychosocial adjustment to multiple sclerosis diagnosis: A meta-review of systematic reviews
Topcu, G., Griffiths, H., Bale, C., Trigg, E., Clarke, S., Potter, K.-J., Mhizha-Murira, J. R., Drummond, A., Evangelou, N., Fitzsimmons, D., et al. (2020) · Clinical Psychology Review · doi:10.1016/j.cpr.2020.101923 · Cited by 50
Calandri, E., Graziano, F., Borghi, M., & Bonino, S. (2017) · Disability and Rehabilitation · doi:10.1080/09638288.2016.1198430 · Cited by 49
Kiropoulos, L. A., Kilpatrick, T., Holmes, A., & Threader, J. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-1152-7 · Cited by 50
“Firstly, the time around receiving a MS diagnosis has been shown to be when individuals experience significantly higher levels of depression and anxiety [2, 4, 11, 16].”
BackgroundPatient Expression of Emotions and Neurologist Responses in First Multiple Sclerosis Consultations
Piccolo, L. D., Pietrolongo, E., Radice, D., Tortorella, C., Confalonieri, P. A., Pugliatti, M., Lugaresi, A., Giordano, A., Heesen, C., Solari, A., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127734 · Cited by 44
Self-citationAnxiety in multiple sclerosis is related to depressive symptoms and cognitive complaints
Wallis, O. C., Bol, Y., Köhler, S., & Heugten, C. M. V. (2019) · Acta Neurologica Scandinavica · doi:10.1111/ane.13191 · Cited by 43
Calandri, E., Graziano, F., Borghi, M., & Bonino, S. (2017) · Clinical Rehabilitation · doi:10.1177/0269215517695374 · Cited by 47
Giovannetti, A. M., Solari, A., & Pakenham, K. I. (2022) · Disability and Rehabilitation · doi:10.1080/09638288.2021.1960441 · Cited by 38
Self-citationGenova, H. M., Lancaster, K., Lengenfelder, J., Bober, C. P., DeLuca, J., & Chiaravalloti, N. D. (2019) · Journal of Neuropsychology · doi:10.1111/jnp.12185 · Cited by 36
Longitudinal study of alexithymia and multiple sclerosis
Chahraoui, K., Duchene, C., Rollot, F., Bonin, B., & Moreau, T. (2013) · Brain and Behavior · doi:10.1002/brb3.194 · Cited by 37
Effective communication at the point of multiple sclerosis diagnosis
Solari, A. (2014) · Multiple Sclerosis Journal · doi:10.1177/1352458514523061 · Cited by 33
Self-citationRelationship between NeutrophiltoLymphocyte Ratio and Stress in Multiple Sclerosis Patients
Al‐Hussain, F. (2017) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2017/24388.9764 · Cited by 31
Simple action for depression detection: using kinect-recorded human kinematic skeletal data
Li, W., Wang, Q., Liu, X., & Yu, Y. (2021) · BMC Psychiatry · doi:10.1186/s12888-021-03184-4 · Cited by 29
Kalron, A., Aloni, R., & Allali, G. (2018) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2018.07.029 · Cited by 29
Experiences of receiving a diagnosis of multiple sclerosis: a meta-synthesis of qualitative studies
Topcu, G., Mhizha-Murira, J. R., Griffiths, H. P., Bale, C., Drummond, A. E., Fitzsimmons, D. F., Potter, K.-J., Evangelou, N., & das Nair, R. (2022) · Disability and Rehabilitation · doi:10.1080/09638288.2022.2046187 · Cited by 39
Kiropoulos, L., Ward, N., & Rozenblat, V. (2021) · Journal of Health Psychology · doi:10.1177/1359105319871639 · Cited by 24
‘It’s the unknown’ – understanding anxiety: from the perspective of people with multiple sclerosis
Butler, E., Thomas, R., Carolan, A., Silber, E., & Chalder, T. (2018) · Psychology and Health · doi:10.1080/08870446.2018.1541989 · Cited by 25
Seyedsaadat, S. M., Hosseininezhad, M., Bakhshayesh, B., Saadat, S. N. S., & Sp, N. (2013) · Neurological Sciences · doi:10.1007/s10072-013-1593-4 · Cited by 24
Driving performance in persons with mild to moderate symptoms of multiple sclerosis
Devos, H., Brijs, T., Alders, G., Wets, G., & Feys, P. (2013) · Disability and Rehabilitation · doi:10.3109/09638288.2012.731468 · Cited by 24
Rintala, A., Matcham, F., Radaelli, M., Locafaro, G., Simblett, S. K., Pietro, C. B. D. S., Bulgari, V., Burke, P., Devonshire, J., Weyer, J., et al. (2019) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2019.109761 · Cited by 22
Biopsychosocial Correlates of Quality of Life in Multiple Sclerosis Patients
Batista, A. R., Silva, S., Lencastre, L., & Guerra, M. P. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192114431 · Cited by 20
Donisi, V., Gajofatto, A., Mazzi, M. A., Gobbin, F., Busch, I. M., Ghellere, A., Klonova, A., Rudi, D., Vitali, F., Schena, F. F., et al. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.598726 · Cited by 20
The emotional disorders associated with multiple sclerosis
Raimo, S., Santangelo, G., & Trojano, L. (2021) · Handbook of clinical neurology · doi:10.1016/b978-0-12-822290-4.00009-8 · Cited by 20
Ghahremani, A., Farkhani, S. M., Baniasadi, M., Hojjat, S. K., Ahmadabad, H. N., Salarbashi, D., Elyasi, S., & Davoodian, N. (2022) · Brain and Behavior · doi:10.1002/brb3.2596 · Cited by 18
Multiple sclerosis and anxiety: Is there an untapped opportunity for exercise?
Šilić, P., Motl, R. W., & Duffecy, J. L. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.104698 · Cited by 18
Culicetto, L., Buono, V. L., Donato, S., Tona, A. L., Cusumano, A. M. S., Corello, G. M., Sessa, E., Rifici, C., D’Aleo, G., Quartarone, A., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13185505 · Cited by 25
The Communication of Multiple Sclerosis Diagnosis: The Patients’ Perspective
Messina, M., Costa, G. D., Rodegher, M., Moiola, L., Colombo, B., Comı, G., & Martinelli, V. (2015) · Multiple Sclerosis International · doi:10.1155/2015/353828 · Cited by 18
Self-citationThe clinical correlates of participation levels in people with multiple sclerosis
Allataifeh, E., Khalil, H. W., Almhdawi, K. A., Al‐Sharman, A., Hawamdeh, Z. M., El‐Salem, K., & Bumın, G. (2020) · Neurorehabilitation · doi:10.3233/nre-203131 · Cited by 16
Clinical correlates of state and trait anxiety in multiple sclerosis
Menculini, G., Gentili, L., Gaetani, L., Mancini, A., Sperandei, S., Sabatino, E. D., Chipi, E., Salvadori, N., Tortorella, A. A. V., Parnetti, L., et al. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.104431 · Cited by 18
Giordano, A., Lugaresi, A., Confalonieri, P. A., Granella, F., Radice, D., Trojano, M., Martinelli, V., Solari, A., on behalf of the SIMS-Practice group, Giordano, A., et al. (2014) · Multiple Sclerosis Journal · doi:10.1177/1352458513519180 · Cited by 16
Self-citationUccelli, M. M., Traversa, S., & Ponzio, M. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.07.039 · Cited by 15
Grech, L., Hunter, A., das Nair, R., Borland, R., & Marck, C. H. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.103289 · Cited by 13
Brożek, P., Brachmanska, M., Rabiczko, K., Bulska, W., Ciułkowicz, M., & Krzystanek, E. (2017) · PubMed · Cited by 13
Anxiety in Argentinian patients with multiple sclerosis: Prevalence and associated factors
Chertcoff, A. S., Curbelo, M. C., Bauer, J. J., Ferrandina, F., Martinez, A., Steinberg, J. D., & Carrá, A. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102042 · Cited by 13
Giovannetti, A. M., Pakenham, K. I., Presti, G., Quartuccio, M. E., Confalonieri, P., Bergamaschi, R., Grobberio, M., Di Filippo, M., Micheli, M., Brichetto, G., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0267245 · Cited by 11
“Because MS onset is usually between 20 and 40 years old [5], the disease has the potential to severely impact most life domains [6, 7].”
BackgroundSelf-citationPiras, G., Rattazzi, L., McDermott, A., Deacon, R. M. J., & D’Acquisto, F. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00400 · Cited by 12
Prognostication and contemporary management of clinically isolated syndrome
Allen, C. M., Mowry, E. M., Tintoré, M., & Evangelou, N. (2020) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-323087 · Cited by 15
Haag, C., Steinemann, N., Chiavi, D., Kamm, C. P., Sieber, C., Manjaly, Z., Horváth, G., Ajdacic‐Gross, V., Puhan, M. A., & von Wyl, V. (2023) · PLOS Digital Health · doi:10.1371/journal.pdig.0000305 · Cited by 11
Montanari, E., Rottoli, M., Maimone, D., Confalonieri, P. A., Plewnia, K., Frigo, M., Francia, A., Pala, A., Losignore, N. A., Ragonese, P., et al. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.02.047 · Cited by 11
Self-citationMeek, C., Topcu, G., Moghaddam, N., & das Nair, R. (2021) · Disability and Rehabilitation · doi:10.1080/09638288.2020.1734105 · Cited by 10
Adalat, M., Khalili, M., Ayromlou, H., Haririan, S., Fazljou, S. M. B., Rezaeizadeh, H., Safari, A. A., & Zargaran, A. (2019) · Galen Medical Journal · doi:10.31661/gmj.v8i0.1212 · Cited by 10
Paediatric Multiple Sclerosis: A Scoping Review of Patients’ and Parents’ Perspectives
Luca, M., Ortega-Castro, N., & Patti, F. (2021) · Children · doi:10.3390/children9010011 · Cited by 10
Neuropsychiatric Status of Patients With Multiple Sclerosis Across Disease Duration Intervals
Freedman, D., Oh, J., & Feinstein, A. (2023) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.20220124 · Cited by 15
Psychosocial difficulties of individuals with multiple sclerosis: the PARADISE-24 questionnaire
Giovannetti, A. M., Schiavolin, S., Raggi, A., Quintas, R. M. M., Černiauskaitė, M., Confalonieri, P. A., Mantegazza, R., Clerici, V. T., Antozzi, C. G., Brenna, G., et al. (2016) · International Journal of Rehabilitation Research · doi:10.1097/mrr.0000000000000194 · Cited by 9
Self-citationDepression and Anxiety in Association with Polypharmacy in Patients with Multiple Sclerosis
Baldt, J., Frahm, N., Hecker, M., Streckenbach, B., Langhorst, S. E., Mashhadiakbar, P., Burian, K., Meißner, J., Heidler, F., Richter, J., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12165379 · Cited by 11
Güner, M. C., Yazar, M. S., & Meterelliyoz, K. Ş. (2020) · The European Journal of Psychiatry · doi:10.1016/j.ejpsy.2020.06.004 · Cited by 8
Predictors of changes in suicidality in multiple sclerosis over time
Flood, S., Foley, F. W., Zemon, V. M., Picone, M., Bongardino, M., & Quinn, H. (2013) · Disability and Rehabilitation · doi:10.3109/09638288.2013.822570 · Cited by 8
Neurobehavioral burden of multiple sclerosis with nanotheranostics
Sriramoju, B., Kanwar, R., & Kanwar, J. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s82768 · Cited by 7
Nogales-Gaete, J., Rodrigo Aracena, C., Sergio Cepeda, Z., Claudio Eloiza, C., Paula Agurto, M., Díaz, V., Labbé, S., Martínez, S., Flores, J., & Araya, C. (2014) · Revista médica de Chile · doi:10.4067/s0034-98872014000500002 · Cited by 8
Kiropoulos, L., Kilpatrick, T., Kalincek, T., Cherulov, L., Mcdonald, E., Wijeratne, T., Threader, J., Rozenblat, V., Simpson-O’Brien, N., van der Walt, A., et al. (2020) · Trials · doi:10.1186/s13063-019-4018-8 · Cited by 8
Healthier living with MS: The key role of self-efficacy and emotion regulation
Dehghan, M., Sharifi, P., Hasani, J., Young, C. A., & Langdon, D. W. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.104608 · Cited by 10
Bazmi, E., Behnoush, A. H., Eskandarieh, S., Moghadasi, A. N., Navardi, S., Ayoubi, S., Behnoush, B., Forouzesh, M., & Sahraian, M. A. (2025) · Brain and Behavior · doi:10.1002/brb3.70458 · Cited by 7
Bonino, S., Calandri, E., & Cattelino, E. (2025) · Social Sciences & Humanities Open · doi:10.1016/j.ssaho.2025.101620 · Cited by 7
Graziano, F., Calandri, E., Borghi, M., & Bonino, S. (2019) · Women & Health · doi:10.1080/03630242.2019.1626789 · Cited by 7
Negative and positive personification of multiple sclerosis: Role in psychological adaptation
Aloni, R., Shahar, G., Ben-Ari, A., Margalit, D., & Achiron, A. (2022) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2022.111078 · Cited by 7
Maniscalco, G. T., Ziello, A. R., Panetta, V., Guarcello, G., & Improta, G. (2019) · Archives of Depression and Anxiety · doi:10.17352/2455-5460.000041 · Cited by 6
Tabatabaei, R. H., & Bolghan‐Abadi, M. (2020) · Zahedan Journal of Research in Medical Sciences · doi:10.5812/zjrms.69355 · Cited by 6
Psychometric Properties of the Persian Version of the PARADISE-24 Questionnaire
Azimi, A., Doosti, R., Samani, S. M. V., Roostaei, B., Gashti, S. H., Navardi, S., & Ghajarzadeh, M. (2021) · International Journal of Preventive Medicine · doi:10.4103/ijpvm.ijpvm_300_19 · Cited by 6
Argento, O., Piacentini, C., Bossa, M., & Nocentini, U. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192416408 · Cited by 4
Fatigue and depression influence the prevalence of anxiety in patients with multiple sclerosis
Nyári, A., Kokas, Z., Szamosi, S., Fricska‐Nagy, Z., Kincses, Z. T., Füvesi, J., Biernacki, T., Klivènyi, P., Bencsik, K., & Sandi, D. (2024) · Neurological Sciences · doi:10.1007/s10072-024-07737-9 · Cited by 6
Peculiarities of sleep problems in multiple sclerosis
Leonavičius, R. (2015) · Neurology Psychiatry and Brain Research · doi:10.1016/j.npbr.2015.09.001 · Cited by 5
Kane, A., Thompson, N. R., & Sullivan, A. B. (2021) · International Journal of MS Care · doi:10.7224/1537-2073.2020-131 · Cited by 5
Riggott, C., Fairbrass, K. M., Guthrie, E., Black, C. J., Selinger, C. P., Ford, A. C., & Gracie, D. J. (2025) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.70431 · Cited by 4
Patients’ Perspective on the Psychological Impact of Multiple Sclerosis on Their Life
Baka, C., Chatira, K., Karademas, E. C., & Kafetsios, K. G. (2021) · Illness Crisis & Loss · doi:10.1177/10541373211006883 · Cited by 4
MULTİPL SKLEROZ HASTALARINDA ANKSİYETENİN MOTOR İMGELEME BECERİSİNE ETKİSİ
Kahraman, T., Savcı, S., Özdoğar, A. T., Gedik, Z., & İdıman, E. (2018) · Türk fizyoterapi ve rehabilitasyon dergisi · doi:10.21653/tjpr.416619 · Cited by 4
McDaniel, H. R., LaGanke, C. C., Bloom, L., Goldberg, S., Hensel, J., Lantigua, L. A., Lages, L. C., Atlas, S. E., Woolger, J. M., & Lewis, J. E. (2019) · Journal of Dietary Supplements · doi:10.1080/19390211.2019.1651435 · Cited by 3
Minacapelli, E., Giordano, A., Falautano, M., Sangalli, F., Pietrolongo, E., Lorefice, L., Cocco, E. E., Lugaresi, A., Comı, G., Filippi, M., et al. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.117064 · Cited by 3
Self-citationThe effect on the anxiety level of the social support given to multiple sclerosis patients
Yılmaz, T. A., & Özdelikara, A. (2021) · Perspectives In Psychiatric Care · doi:10.1111/ppc.12807 · Cited by 3
Anxiety Sensitivity and Its Relation to Anxiety in Multiple Sclerosis
Yazar, M. S., & Meterelliyoz, K. Ş. (2021) · Psychiatry and Clinical Psychopharmacology · doi:10.5152/pcp.2021.21039 · Cited by 3
Ibrahim, M., Henry, A., Khaled, K. A., Bensa, C., Moreau, T., Montreuil, M., & Tourbah, A. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.103758 · Cited by 3
Diagnosis concealment is prevalent in MS, and associated with diagnosis experience
Leavitt, V. M., Kever, A., Weinstein, S. M., Shinohara, R. T., Schmidt, H. K., Aoun, S. M., Solari, A., & Solomon, A. J. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.104373 · Cited by 3
Self-citationWills, O. C., Manche, S., & Probst, Y. (2024) · Health Expectations · doi:10.1111/hex.70091 · Cited by 3
Anxiety and Multiple Sclerosis
Magistrale, G., & Nocentini, U. (2015) · Neuropsychiatric symptoms of neurological disease · doi:10.1007/978-3-319-18464-7_4 · Cited by 3
Psychology of Multiple Sclerosis
Foley, F. (2015) · Neuropsychiatric symptoms of neurological disease · doi:10.1007/978-3-319-18464-7_9 · Cited by 2
Psychopathology of Alexithymia and Multiple Sclerosis
Chahraoui, K., Dieu, E., & Moreau, T. (2015) · Neuropsychiatric symptoms of neurological disease · doi:10.1007/978-3-319-18464-7_14 · Cited by 3
Impact of remoteness on patient outcomes for people with multiple sclerosis in Australia
Chen, J., Ahmad, H., Taylor, B. V., Palmer, A. J., & van der Mei, I. A. F. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.103208 · Cited by 3
Giovannetti, A. M., Quintas, R., Maggiolo, S., & Quartuccio, M. E. (2024) · Disability and Rehabilitation · doi:10.1080/09638288.2023.2290690 · Cited by 2
Bahmani, B., Mehraban, S., Azkhosh, M., Khanjani, M. S., & Azimian, M. (2022) · Iranian Journal of Psychiatry and Behavioral Sciences · doi:10.5812/ijpbs-127590 · Cited by 2
Mahboobi, M., Khashandish, A., Moghadasi, A. N., Sahraian, M. A., Hidaji, M. B., & Etesam, F. (2022) · Current Journal of Neurology · doi:10.18502/cjn.v20i4.8347 · Cited by 2
Aloni, R., Asher, G., Ben-Ari, A., & Menascu, S. (2024) · Children · doi:10.3390/children11080929 · Cited by 4
Metadata
- Authors
- Giordano, A., Granella, F., Lugaresi, A., Martinelli, V., Trojano, M., Confalonieri, P., Radice, D., & Solari, A.
- Affiliations
- Fondazione IRCCS Istituto Neurologico Carlo Besta (IT)
- University of Parma (IT)
- University of Chieti-Pescara (IT)
- IRCCS Ospedale San Raffaele (IT)
- European Institute of Oncology (IT)
- Corresponding author
- Solari, Alessandra
- Venue
- Journal of the Neurological Sciences
- Publisher
- Elsevier BV
- Published
- 2011-08
- Volume
- 307
- Issue
- 1-2
- Pages
- 86-91
- ISSN
- 0022-510X (ISSN-L)
- OpenAlex
- W1998970209
- Cited by
- 123
- References
- 41
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 7 · 2023: 8 · 2022: 11 · 2021: 15 · 2020: 12 · 2019: 13 · 2018: 6 · 2017: 4 · 2016: 8 · 2015: 12 · 2014: 8 · 2013: 10 · 2012: 3
- FWCI
- 4.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of the Neurological Sciences (publishedVersion)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion)
- CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro) (submittedVersion)
- Funders
- Fondazione Italiana Sclerosi Multipla (2007/R/19)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Keywords
- multiple sclerosis, anxiety, depressive symptoms, diagnosis disclosure, sex differences, predictors of anxiety, Hospital Anxiety and Depression Scale
- MeSH terms
- Adult, Anxiety, Anxiety Disorders, Depression, Depressive Disorder, Diagnostic Techniques, Neurological, Female, Humans, Male, Middle Aged, Multiple Sclerosis, Prospective Studies, Comorbidity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review